Vident Investment Advisory’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,899
Closed -$202K 1374
2022
Q3
$202K Buy
14,899
+1,909
+15% +$30K 0.01% 999
2022
Q2
$101K Buy
+12,990
New +$112K ﹤0.01% 1194
2022
Q1
Sell
-10,640
Closed -$187K 1357
2021
Q4
$187K Buy
+10,640
New +$206K ﹤0.01% 1138
2021
Q3
Sell
-6,052
Closed -$200K 1264
2021
Q2
$200K Buy
+6,052
New +$228K 0.01% 1065

Other funds holding ONEM

Vident Investment Advisory's ONEM Position: Q4 2022 in Review

Vident Investment Advisory sold out of 1Life Healthcare (ONEM) in Q4 2022, closing a stake of 14,899 shares — an estimated $202K sold.

Vident Investment Advisory first reported a position in ONEM in Q2 2021 and held it in 4 quarters. The position peaked at $202K in Q3 2022. 230 funds tracked by Wall St. Rank hold ONEM as of Q4 2022.

  • Vident Investment Advisory reported no remaining 1Life Healthcare position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 14,899 1Life Healthcare shares in Q4 2022, an estimated $202K.
  • Vident Investment Advisory first reported a position in 1Life Healthcare in Q2 2021 and held it in 4 quarters.
  • Vident Investment Advisory's 1Life Healthcare position peaked at $202K in Q3 2022.
  • 230 funds tracked by Wall St. Rank held 1Life Healthcare as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.